Esperion Therapeutics, Inc. (ESPR): Price and Financial Metrics
ESPR Price/Volume Stats
| Current price | $2.21 | 52-week high | $3.94 |
| Prev. close | $2.26 | 52-week low | $1.58 |
| Day low | $2.17 | Volume | 2,550,300 |
| Day high | $2.31 | Avg. volume | 5,066,891 |
| 50-day MA | $2.46 | Dividend yield | N/A |
| 200-day MA | $2.23 | Market Cap | 435.45M |
ESPR Stock Price Chart Interactive Chart >
Esperion Therapeutics, Inc. (ESPR) Company Bio
Esperion Therapeutics is focused on developing and commercializing first-in-class, oral, LDL-cholesterol-lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company was founded in 1998 and is based in Ann Arbor, Michigan.
ESPR Price Returns
| 1-mo | 0.91% |
| 3-mo | 3.76% |
| 6-mo | -5.56% |
| 1-year | 9.41% |
| 3-year | -41.53% |
| 5-year | -95.93% |
| YTD | 0.45% |
| 2024 | -26.42% |
| 2023 | -52.01% |
| 2022 | 24.60% |
| 2021 | -80.77% |
| 2020 | -56.40% |
Continue Researching ESPR
Want to do more research on Esperion Therapeutics Inc's stock and its price? Try the links below:Esperion Therapeutics Inc (ESPR) Stock Price | Nasdaq
Esperion Therapeutics Inc (ESPR) Stock Quote, History and News - Yahoo Finance
Esperion Therapeutics Inc (ESPR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...